1. Home
  2. Documents
  3. Regional Update, Influenza. Epidemiological Week 26 (13 July 2022)

Regional Update, Influenza. Epidemiological Week 26 (13 July 2022)

Regional Update, Influenza. Epidemiological Week 26 (13 July 2022)
Download from the PAHO Digital Library

North America: Overall, influenza activity decreased in the subregion, while SARS-CoV-2 continued to rise. In Mexico, influenza activity with A(H3N2) virus predominance decreased, and SARS-CoV-2 positivity continued to increase; ILI and SARI activity remained at moderate intensity levels. In the United States, influenza activity was low, with influenza A(H3N2) viruses predominating. In addition, RSV and SARS-CoV-2 activity increased with higher COVID-19-associated hospitalizations.

Caribbean: Influenza activity remained very low, with the influenza A(H3N2) virus predominance. However, Belize, the Dominican Republic, and Haiti reported increased SARS-CoV-2 activity, with increased SARI cases for this time of year in the last one. In addition, in the Dominican Republic, RSV activity remained elevated at levels seen in the pre-pandemic period.

Central America: Influenza activity appeared to decrease in the subregion, influenza A(H3N2) virus predominated. In El Salvador and Nicaragua, influenza activity continued elevated, with the A(H3N2) virus predominance. SARS-CoV-2 activity remained moderate and rising across the subregion. Influenza and SARS-CoV-2-associated ILI counts remained at moderate levels in Guatemala.

Andean Countries: Influenza activity remained low with A(H3N2) predominance and circulation above epidemic levels in Bolivia. However, in Colombia and Peru, SARS-CoV-2 activity continued to increase. In Bolivia, SARI activity remained elevated to epidemic levels and was associated with the co-circulation of influenza, SARS-CoV-2, and RSV.

Brazil and Southern Cone: Overall, influenza activity remained at moderate levels; influenza A(H3N2) prevailed. At moderate levels, SARS-CoV‐2 activity continued to increase throughout the subregion. Chile, Paraguay, and Uruguay reported elevated SARI activity above the average expected at this time of year, with RSV and SARS-CoV-2 predominance in Chile and Paraguay, while influenza and SARS-CoV-2 predominated in Uruguay.